Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Guerriaud

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revue D'Histoire De La Pharmacie|July 21, 2015
[Studying at École de pharmacie de Lille with Alfred Giard in the XIXth century]Mathieu Guerriaud
Pharmaceutical Medicine|December 9, 2023
"Regulatory Sandboxes" Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal ProductsMathieu Guerriaud
European Journal of Health Law|January 25, 2024
The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal ProductsMathieu Guerriaud, Valérie Siranyan
Frontiers in Medicine|November 3, 2022
RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislationMathieu Guerriaud, Evelyne Kohli
Actualites Pharmaceutiques|September 29, 2021
[The pharmacist and informed consent]Jean-Michel Mrozovski, Mathieu Guerriaud
Gene Therapy|March 1, 2024
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidateMathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
Low Cross-Reactivity Between Cisplatin and Other Platinum SaltsJustine Pasteur, Laure Favier, Corinne Pernot, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 7, 2023
Why is there no biosimilar of Erbitux®?Emmanuel Douez, Valentina D'Atri, Davy Guillarme, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revue D'Histoire De La Pharmacie|July 21, 2015
[Studying at École de pharmacie de Lille with Alfred Giard in the XIXth century]Mathieu Guerriaud
Pharmaceutical Medicine|December 9, 2023
"Regulatory Sandboxes" Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal ProductsMathieu Guerriaud
European Journal of Health Law|January 25, 2024
The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal ProductsMathieu Guerriaud, Valérie Siranyan
Frontiers in Medicine|November 3, 2022
RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislationMathieu Guerriaud, Evelyne Kohli
Actualites Pharmaceutiques|September 29, 2021
[The pharmacist and informed consent]Jean-Michel Mrozovski, Mathieu Guerriaud
Gene Therapy|March 1, 2024
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidateMathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
Low Cross-Reactivity Between Cisplatin and Other Platinum SaltsJustine Pasteur, Laure Favier, Corinne Pernot, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 7, 2023
Why is there no biosimilar of Erbitux®?Emmanuel Douez, Valentina D'Atri, Davy Guillarme, et al.
Pageof 1